ACN | AccentureNYSETechnologyCommon stock golden cross and death cross projections, cross tests and history

$254.56
-$6.38 (-2.45%)

Accenture (ACN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $254.56 vs 50 $205.63 / 200 $191.09
Projection
No cross projected
Test
No active test
Last cross
Golden cross 21 Oct 2026 ยท projected 16 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $258.24 vs 50 $204.71 / 200 $285.64
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 6 Oct 2025 ยท projected 23 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $255.85 vs 50 $224.75 / 200 $179.30
Projection
No cross projected
Test
No active test
Last cross
Golden cross 24 Aug 2026 ยท projected 29 bars out

Cross history

21
crosses on record since 2018
10 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
21 Oct 2026Golden steepdaily16 bars outNot tested
24 Aug 2026Golden4-hour29 bars outNot tested
19 Feb 2026Death4-hour26 bars outNot tested
10 Dec 2025Golden4-hour24 bars outNot tested
week of 6 Oct 2025Death steepweekly23 bars outNot tested

About ACN

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$1B
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorTechnology
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.